Previous Article | Next Article 
Infection and Immunity, September 1998, p. 4043-4049, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Contributions of Reactive Oxygen Intermediates and
Reactive Nitrogen Intermediates to Listericidal Mechanisms Differ
in Macrophages Activated Pre- and Postinfection
Satoshi
Ohya,1,2,*
Yoshinari
Tanabe,1,2
Masato
Makino,1,2
Takamasa
Nomura,3
Huabao
Xiong,1
Masaaki
Arakawa,2 and
Masao
Mitsuyama3
Departments of
Bacteriology1 and
Internal Medicine
(II),2 Niigata University School of Medicine,
Niigata 951-8510, and
Department of Microbiology, Graduate
School of Medicine, Kyoto University, Kyoto
606-8501,3 Japan
Received 29 December 1997/Returned for modification 23 March
1998/Accepted 3 June 1998
 |
ABSTRACT |
The contribution of reactive oxygen intermediates (ROI) and
reactive nitrogen intermediates (RNI) to the killing of Listeria monocytogenes by macrophages activated by addition of spleen
cells from listeria-immune mice plus specific antigen was examined. When macrophages were infected with L. monocytogenes and
then spleen cells were added, there was not as big a difference in listericidal activity between macrophages cultured with normal spleen
cells and those cultured with immune spleen cells as expected. In this
culture system, RNI was mainly involved in the macrophage intracellular
killing. In macrophages first activated and then infected, a
significant level of enhanced killing was observed. Blockade of ROI
production drastically affected the enhanced killing ability, while
inhibition of RNI production had a negligible effect. Thus, the
contributions of ROI and RNI to listericidal mechanisms of macrophages
were different between macrophages activated at pre- and postinfection
stages.
 |
INTRODUCTION |
Listeria monocytogenes is
a facultative intracellular pathogen capable of escaping the killing
mechanism of macrophages (24, 25). Mice that have survived a
primary infection with L. monocytogenes experience
protective immunity and are able to eliminate the bacteria much faster
than in the primary infection (18). The protective immunity
is believed to be mediated by both CD4+ and
CD8+ T cells in mice (14).
The enhanced bacterial elimination expressed in the immune mice depends
mainly on the enhanced killing of macrophages activated by various
cytokines, especially gamma interferon (IFN-
). As we have shown in
the previous studies, the main source of IFN-
during a secondary
infection is antigen-specific CD4+ T cells (29,
31). In contrast, in primary infection IFN-
is secreted mainly
by natural killer (NK) cells stimulated with interleukin-1
(IL-1
), IL-12, and tumor necrosis factor alpha, which are secreted
by macrophages (32). Although IFN-
is endogenously produced in both the primary and secondary infections, the ultimate bacterial elimination is quite different.
Reactive nitrogen intermediates (RNI), including nitric oxide, are
involved in the antimicrobial activity of activated macrophages against
a variety of intracellular microorganisms, e.g., Leishmania major (17), Toxoplasma gondii (1,
15), Legionella pneumophila (3),
Mycobacterium tuberculosis (4),
Mycobacterium bovis BCG (9), and L. monocytogenes (2), as are reactive oxygen intermediates
(ROI). There have been conflicting results on the involvement of RNI in
the course of Listeria infection (11). Recent
reports show that mice deficient in inducible nitric oxide synthase
(iNOS) were not able to eliminate L. monocytogenes as efficiently as did control mice during a primary infection
(19); however, acquired resistance against the secondary
infection was not impaired, suggesting that the immune resistance is
not dependent on RNI (28).
In the present study, we attempted to analyze the involvement of ROI
and RNI in the listericidal mechanisms used by macrophages during
primary and secondary infections in vitro. In addition, we investigated
the kinetics of IFN-
and nitric oxide production in primary and
secondary infection to elucidate the mechanism of enhanced killing in
the secondary infection.
 |
MATERIALS AND METHODS |
Experimental animals.
Male C3H/He mice (Charles River Japan,
Atsugi, Japan), raised and maintained under specific-pathogen-free
conditions, were used at the age of 7 to 9 weeks.
Preparation of bacteria.
L. monocytogenes EGD, a
virulent and highly immunogenic strain, was used throughout the study.
The bacteria were grown in tryptic soy broth (Difco Laboratories,
Detroit, Mich.) at 37°C for 16 h, washed repeatedly, suspended
in phosphate-buffered saline, and stored at
70°C until used. Killed
cells of L. monocytogenes were prepared by heating the
viable bacterial suspension of a known concentration at 74°C for 90 min (29).
Reagents.
Superoxide dismutase (SOD),
NG-monomethyl-L-arginine
(L-NMMA), and
NG-monomethyl-D-arginine
(D-NMMA) were purchased from Wako Pure Chemicals, Inc.
(Osaka, Japan). Gentamicin reagent solution was purchased from Life
Technologies, Inc. (Grand Island, N.Y.). SOD and NMMA were added to the
cultures at final concentrations of 100 U/ml and 1 mM, respectively.
Preparation of macrophages.
Peritoneal exudate cells (PEC)
were recovered from C3H/He mice 3 days after an intraperitoneal
injection of 1.5 ml of 10% Proteose Peptone (Difco). The PEC were
washed with Hanks' balanced salt solution (HBSS) and suspended in
medium consisting of RPMI 1640 (Flow Laboratories, Inc., McLean, Va.)
supplemented with 10% heat-inactivated fetal bovine serum, 10 µg of
gentamicin/ml, 5 g of HEPES/liter, and 2 g of
NaHCO3/liter. PEC (106) were cultured in a
24-well flat-bottom tissue culture plate (Costar, Cambridge, Mass.) for
2 h at 37°C, nonadherent cells were removed by gentle washing
with warm HBSS, and the culture medium was replaced with 1 ml of fresh
medium per well. Adherent cells thus prepared were used as macrophages.
Immunization of mice and preparation of immune spleen cells and
normal spleen cells.
Mice were immunized by an intravenous
injection with 2 × 103 viable L. monocytogenes cells. One week after the immunization, spleens were
removed and single-cell suspensions were prepared. The cells were
suspended at 5 × 106 cells per ml in the medium and
were used as immune spleen cells. Normal spleen cells were prepared
from nonimmunized mice.
Activation of macrophages.
Adherent macrophages
(106) were infected with L. monocytogenes, and
extracellular bacteria were removed by washing and killed with
gentamicin-containing medium. Then immune spleen cells (5 × 106) or normal spleen cells (5 × 106)
were added to activate macrophages (postinfection). For preinfection activation, macrophages were incubated with immune spleen cells (5 × 106) and killed L. monocytogenes cells
(2 × 107) for 12 h, washed to remove spleen
cells and killed L. monocytogenes cells, and used for the
intracellular killing assay.
Intracellular killing assay.
The intracellular killing assay
was performed by the method described recently (23). In
brief, adherent macrophages were infected with L. monocytogenes at a 20:1 ratio of bacteria to cells and the plates
were centrifuged at 450 × g for 5 min to enhance the
attachment of bacteria to macrophages and incubated at 37°C for 60 min to facilitate the ingestion of bacteria. After phagocytosis, the
cells were washed seven times with 1 ml of warm HBSS, and 5 µg of
gentamicin/ml was added to the culture medium. The cells were incubated
for 4 h to kill extracellular bacteria. It was confirmed that this
was sufficient to kill the extracellular bacteria without affecting the
intracellular killing (23). Several hours later, the cells
were disrupted with sterile distilled water to release the
intracellular bacteria. The number of bacteria inside the macrophages
was determined by serial dilution and plating on brain heart infusion
agar (Eiken Chemical Co., Ltd., Tokyo, Japan).
Nitrite determination.
The nitrite concentration in culture,
a measurement of nitric oxide synthesis, was assayed by a standard
Griess reaction adapted to microplates as described previously
(31). The Griess reagent was prepared by mixing equal
volumes of sulfanilamide (1.5% in 5% H3PO4)
and naphthylethylene diamine dihydrochloride (0.1% in H2O). A 100-µl volume of reagent was mixed with an equal
volume of supernatant and incubated at room temperature for 10 min. The absorbance of the chromophore formed was measured at 540 nm in an
automated microplate reader. Nitrite was quantitated with
NaNO2 as a standard, and the data were expressed as
micromoles of nitrite per liter.
IFN-
assay.
The IFN-
titer in the supernatant was
determined by an enzyme-linked immunosorbent assay as described
previously (13). Briefly, the supernatant and recombinant
mouse IFN-
(a gift from Central Research Institute, Daiichi Seiyaku
Co. Ltd.) were placed in the wells of enzyme immunoassay plates
precoated with rat anti-mouse IFN-
monoclonal antibody (Lee
Biomolecular Research Inc., San Diego, Calif.) and 0.5% bovine serum
albumin in carbonate-bicarbonate buffer (pH 9.6). After incubation for
90 min, the plates were washed and incubated with rabbit anti-mouse
IFN-
polyclonal antibody for 90 min. After the plates were washed,
peroxidase-conjugated goat anti-rabbit immunoglobulin G (Zymed
Laboratories, Inc., San Francisco, Calif.) was added, and the mixture
was incubated for 90 min. The plates were washed, and then
orthophenylenediamine in phosphate buffer (pH 5.0) with 0.03%
H2O2 was added as a substrate solution. The
reaction was terminated by adding 2.5 M H2SO4,
and the absorbance was measured at 490 nm.
Luminol-dependent chemiluminescence.
Luminol-dependent
chemiluminescence was determined by using a lumiphotometer (TD-4000;
Labo Science, Tokyo, Japan) as described previously (34).
PEC were washed with buffer II, consisting of 10 mM HEPES, 5 mM KCl,
145 mM NaCl, and 5.5 mM glucose (pH 7.4), scraped with a cell scraper,
and suspended to yield 107 cells/ml in 50 µl of buffer
II. Then 50 µM luminol sodium salt (Wako), 100 µl of buffer I
(consisting of buffer II supplemented with 1 mM CaCl2), and
50 µl of phorbol myristate acetate (20 µg/ml) were added to the
cells. Chemiluminescence was monitored by the lumiphotometer for 10 min
and expressed in relative light units.
RNA extraction.
Total cellular RNA was extracted by a
previously described method (31). The cells were washed, and
1 ml of solution D (4 M guanidinium isothiocyanate, 0.5%
N-lauroylsarcosine, 25 mM sodium citrate, 0.05 mM
2-mercaptoethanol) was added to the cell pellet. Cells were disrupted
by being passed through a 21-gauge needle. Subsequently, 0.1 ml of 2 M
sodium acetate (pH 4), 1 ml of water-saturated phenol, and 0.2 ml of
chloroform-isoamyl alcohol were added to the mixture, with thorough
mixing by inversion after the addition of each reagent. The final
suspension was vigorously vortexed for 20 s and then cooled on ice
for 15 min. Samples were centrifuged at 10,000 × g for
20 min at 4°C. After centrifugation, the aqueous phase containing RNA
was transferred to a new tube, mixed with the same volume of
isopropanol, and held at
20°C overnight to precipitate RNA. After
centrifugation at 10,000 × g for 20 min, the RNA
pellet was dissolved in solution D and precipitated with the same
volume of isopropanol at
20°C for 2 h. RNA was collected by
centrifugation for 15 min at 4°C, washed once with 75% ethanol, dried, and dissolved in 20 µl of distilled water. The RNA
concentration was measured by monitoring the absorbance at 260 nm with
a spectrophotometer (GeneQuant; Pharmacia LKB Biochem Ltd., Cambridge,
United Kingdom).
RT-PCR and gel electrophoresis.
cDNA was produced by reverse
transcription (RT) as follows (31). The total RNA extracted
(5 µg) was mixed with 4 µl of RT buffer, 2 µl of 0.1 M
dithiothreitol, 0.5 µl of RNasin (Promega, Madison, Wis.), 1 µl of
10 mM deoxynucleoside triphosphates (Pharmacia), 2 µl of random
primer (Pharmacia), 0.5 µl of reverse transcriptase (Gibco-BRL Life
Technologies Inc., Gaithersburg, Md.), and distilled water to give a
total volume of 20 µl. The mixture was incubated at 42°C for 60 min
and then boiled at 95°C for 3 min. The samples were kept at
20°C
until used. The PCR mixture consisted of 2 µl of sample cDNA, 5 µl
of PCR amplification buffer, 2 µl of 25 mM MgCl2, 4 µl
of 2.5 mM deoxynucleoside triphosphates, 0.3 µl of Taq DNA
polymerase (5 U/µl; Promega), 2 µl of 20 µM primer, and 32.7 µl
of double-distilled water to give a final volume of 50 µl. The
sequences of the oligonucleotide primers used are as follows:
5'-CCCTTCCGAAGTTTCTGGCAGCAGC-3' and
5'-GGCTGTCAGAGCCTCGTGGCTTTGG-3' for iNOS and
5'-TGGAATCCTGTGGCATCCATGAAAC-3' and
5'-TAAAACGCAGCTCAGTAACAGTCCG-3' for
-actin. The predicted
sizes of the amplified products for iNOS and
-actin were 497 and 348 bp, respectively. PCR amplification was performed with a TP cycler 100 (Toyobo, Osaka, Japan). The PCR program was one cycle of 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min followed by amplification
for 23 cycles for
-actin and 25 cycles for iNOS according to the
most appropriate cycle number determined by a preliminary experiment.
The reaction was terminated by incubation at 72°C for 7 min, and the
products were kept at 4°C in the cycler. The PCR products were
analyzed by gel electrophoresis with a 1% low-melting-point agarose
gel (Wako) in 1× TAE (Tris-acetate-EDTA) buffer supplemented with
0.005% ethidium bromide. A 10-µl volume of PCR products and 2 µl
of marker dye were applied to each well. The bands were visualized by a UV transilluminator and photographed.
 |
RESULTS |
Kinetics of intracellular killing of macrophages cultured with
normal or immune spleen cells.
To test the listericidal activity
of macrophages in primary and secondary infections, we first evaluated
the enhancement of listericidal activity of macrophages cultured with
spleen cells from mice immunized with L. monocytogenes or
not immunized. Macrophages were infected with L. monocytogenes, washed with HBSS, and incubated for 4 h in
gentamicin-containing medium to kill extracellular bacteria, and then
normal or immune spleen cells were added to infected macrophages (time
zero). Every 6 h, intracellular viable bacteria were enumerated on
brain heart infusion agar (Fig. 1). When
infected macrophages were cultured with immune spleen cells, the number
of L. monocytogenes cells decreased after 12 h of
incubation. In cultures with normal spleen cells, the number of
bacteria increased during the first 18 h and decreased thereafter.
The difference in bactericidal activity between cultures with normal
and immune spleen cells was not as significant as we had expected.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Kinetics of intracellular killing of L. monocytogenes by macrophages cultured in the presence of spleen
cells after infection. Macrophages (106) were infected with
L. monocytogenes at a multiplicity of infection of 20. After
elimination of extracellular bacteria, 5 × 106 spleen
cells from immune mice ( ) or normal mice ( ) were added to the
infected macrophages. Bacterial counts were determined by serial
dilution and plating after incubation for the indicated times. Data are
representative of three consecutive experiments and are expressed as
the means of triplicate cultures ± standard deviations.
|
|
Next, we examined the IFN-
titer and nitrite concentration in the
supernatant in this assay system (Fig.
2). There was a significant difference in
the production of IFN-
and nitrite between cultures of infected
macrophages with normal or immune spleen cells. Interestingly, the
IFN-
titer and nitric oxide production showed a tendency to increase
even in the culture with normal spleen cells. RT-PCR detection of iNOS
gene expression in this assay system has shown that iNOS mRNA in
macrophages cultured with immune spleen cells reached a peak at around
18 h and that the mRNA level in a culture with normal spleen cells
reached a peak at 24 h or later (Fig.
3).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
Kinetics of IFN- production and nitrite accumulation
in the supernatants of cultures shown in Fig. 1. Normal spleen cells
(A) or immune spleen cells (B) were added to infected macrophages.
Culture supernatants at the indicated time points were subjected to
IFN- titration by enzyme immunoassay and nitrite determination by
using Griess reagent. Data are representative of three consecutive
experiments and are expressed as the means of triplicate cultures + standard deviations.
|
|

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetics of iNOS gene expression in macrophages cultured
with spleen cells after infection. Normal spleen cells (A) or immune
spleen cells (B) were added to infected macrophages. The cells were
incubated, and the total cellular RNA was extracted at the indicated
time points. Total RNA was subjected to RT-PCR to detect iNOS gene
expression.
|
|
Involvement of ROI and RNI in listericidal mechanisms used by
macrophages cultured with normal or immune spleen cells.
Next we
determined the involvement of ROI and RNI in the killing of L. monocytogenes by macrophages in this assay system. SOD and
L-NMMA were employed to inhibit
O2
and nitric oxide production, respectively.
SOD and/or L-NMMA was added to infected macrophages
simultaneously with the addition of spleen cells. Addition of
L-NMMA to give 1 mM in culture resulted in complete
abolition of nitrite production, and SOD did not affect the nitrite
level (Fig. 4). It was found that the
listericidal activity of macrophages cultured with immune spleen cells
was impaired after the addition of L-NMMA (Fig. 4B). The
specific inhibition of nitric oxide production by L-NMMA
could be confirmed by the ineffectiveness of D-NMMA,
employed as a specificity control. It was interesting that the
listericidal activity of macrophages cultured with normal spleen cells
was also affected after addition of L-NMMA (Fig. 4A). In
contrast, SOD did not affect the listericidal activity of macrophages
in this assay system (Fig. 4). These results suggested that nitric
oxide played an important role in the killing of L. monocytogenes by macrophages which were first infected and then
supplemented with normal or immune lymphocytes.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of SOD and NMMA on the intracellular killing of
L. monocytogenes by macrophages cultured in the presence of
spleen cells after infection. Normal spleen cells (A) or immune spleen
cells (B) were added to infected macrophages. SOD and/or L-
or D-NMMA was added to infected macrophages simultaneously
with the addition of spleen cells. Bacterial counts were determined
after incubation for 24 h by serial dilution and plating. Data are
representative of two consecutive experiments and are expressed as the
means of triplicate cultures + standard deviations.
|
|
From the results obtained in the above-described experiments, it was
difficult to explain the well-known difference of bacterial elimination
between the primary and secondary infections in vivo, since there was
no evident difference in bacterial killing by and killing mechanisms of
macrophages in primary- and secondary-infection models in vitro.
Kinetics of intracellular killing by macrophages activated pre- and
postinfection.
We reported previously that ROI but not RNI was
involved in the listericidal mechanisms of macrophages activated by
IFN-
and lipopolysaccharide (LPS) (23), which is not
consistent with the results obtained in the present study. The
activation of macrophages by IFN-
and LPS was completed
preinfection, whereas macrophages cultured with immune spleen cells in
the present assay system were activated postinfection. Therefore, we
compared the macrophages activated pre- or postinfection for their
listericidal activity. Macrophages were cultured with immune spleen
cells (5 × 106) plus killed L. monocytogenes cells (7 × 106) for 12 h to
activate them preinfection. For comparison, a macrophage culture with
killed L. monocytogenes cells in the absence of immune spleen cells was prepared. Then the cells were washed and infected with
viable L. monocytogenes. After elimination of extracellular bacteria, immune spleen cells and killed L. monocytogenes
cells were added again to both types of macrophage culture (time zero). The number of intracellular bacteria was assessed every 6 h (Fig. 5). It was found that preactivated
macrophages could kill intracellular bacteria soon after infection,
whereas the cells activated postinfection allowed the number of
intracellular bacteria to increase for 18 h and then began to kill
these bacteria. This assay system indicated a significant difference in
the intracellular killing activity between macrophages activated pre-
or postinfection.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 5.
Kinetics of intracellular killing of L. monocytogenes by macrophages activated at the pre- or
postinfection stage. Macrophages (106) were cultured with
( ) or without ( ) immune spleen cells (5 × 106)
plus killed L. monocytogenes cells (2 × 107) for activation preinfection for 12 h. Then the
macrophages were washed and infected with L. monocytogenes
at a multiplicity of infection of 20. After elimination of
extracellular bacteria, immune spleen cells (5 × 106)
and killed L. monocytogenes cells (2 × 107) were added to both macrophage cultures. Bacterial
counts were determined after incubation for the indicated times by
serial dilution and plating. Data are representative of three
consecutive experiments and are expressed as the means of triplicate
cultures ± standard deviations.
|
|
Involvement of ROI and RNI in listericidal mechanisms used by
macrophages activated pre- or postinfection.
Next we tried to
determine whether ROI and RNI are involved in the killing of L. monocytogenes by macrophages in this assay system. We found that
the listericidal activity of macrophages activated preinfection was
impaired after the addition of SOD but not after the addition of NMMA
(Fig. 6). This result was the exact
opposite of the results shown in Fig. 4. It was suggested that ROI was
involved mainly in the killing of bacteria by macrophages activated
preinfection, as in macrophages activated preinfection by IFN-
and
LPS (23). In contrast, in macrophages activated postinfection, RNI was essential in the killing of L. monocytogenes and ROI did not appear to contribute.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 6.
Effects of SOD and NMMA on the intracellular killing of
L. monocytogenes by macrophages activated at the
preinfection stage. Macrophages were cultured with immune spleen cells
plus killed L. monocytogenes cells for activation and then
washed and infected with L. monocytogenes at a multiplicity
of infection of 20. SOD and/or NMMA was added to preactivated and
infected macrophages at the time of readdition of the spleen cells.
Bacterial counts were determined after incubation for 24 h by
serial dilution and plating. Data are representative of two consecutive
experiments and are expressed as the means of triplicate cultures + standard deviations.
|
|
We also examined nonactivated and activated macrophages cultured with
normal or immune spleen cells for their ability to produce ROI by means
of luminol-dependent chemiluminescence. Macrophages were cultured with
killed L. monocytogenes cells only or killed L. monocytogenes cells plus normal or immune spleen cells for 12 h, and O2
production was determined (Fig.
7). It was found that macrophages cultured with killed L. monocytogenes cells and immune
spleen cells produced 10 times more O2
than
did nonactivated macrophages. Interestingly, macrophages cultured with
normal spleen cells were also capable of producing O2
to a level half that produced by
macrophages cultured with immune spleen cells. Addition of SOD to give
100 U/ml completely abolished the O2
production in these cultures (data not shown). These results suggested
that nonactivated macrophages, as well as macrophages activated
postinfection, allowed the number of intracellular bacteria to increase
because of the low level of O2
-producing
ability.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 7.
Chemiluminescent response of macrophages cultured in the
presence of spleen cells plus killed L. monocytogenes cells
(KLm). Cells were cultured for 12 h, and then adherent macrophages
were scraped off with a cell scraper and suspended to yield
107 cells/ml in reaction buffer. Macrophages were
stimulated with phorbol myristate acetate, and chemiluminescence was
monitored for 10 min with a lumiphotometer. The results are expressed
in relative light units (rlu). Data are representative of two
consecutive experiments, and peak chemiluminescence is expressed as the
means of triplicate cultures + standard deviations.
|
|
Kinetics of IFN-
and nitric oxide production of macrophages
activated pre- and postinfection.
The above results showed that
when macrophages were activated preinfection, ROI was involved in the
listericidal mechanism and RNI was not. When macrophages were activated
postinfection, the number of intracellular bacteria increased for
20 h after infection, probably because nonactivated macrophages
were not able to produce enough ROI. The killing observed at a later
stage appeared to be attributable to the generation of RNI.
Lastly we investigated whether nitric oxide was actually produced in
this assay system. We found that nitric oxide was produced at the early
stage of infection in macrophages activated preinfection (Fig.
8A) but that RNI was not involved in the
listericidal activity. In macrophages activated postinfection, the
kinetics of nitric oxide production was coincident with the
bactericidal activity (Fig. 8B).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 8.
Kinetics of IFN- production and nitrite accumulation
in the supernatants of the cultures in Fig. 5. Macrophages were
activated preinfection (A) or postinfection (B) by the addition of
immune spleen cells plus killed L. monocytogenes cells. Data
are representative of three consecutive experiments and are expressed
as the means of triplicate cultures + standard deviations.
|
|
 |
DISCUSSION |
Recent reports showed that bacterial elimination in L. monocytogenes infection is mediated by macrophages (27)
and neutrophils (5) in mice. It is generally accepted that
IFN-
is one of the most important cytokines involved in the
activation of macrophages. When macrophages are stimulated with IFN-
and other cytokines, ROI production is enhanced (20, 21) and
RNI production is induced (8, 22). However, whether these
effector molecules are involved in the killing during primary and
secondary infection has not been completely elucidated. In particular,
the involvement of nitric oxide seems to be controversial. Several
studies support the critical role of nitric oxide in host defense
against L. monocytogenes in vivo in primary infection
(2, 19). We also reported that nitric oxide is an important
mediator of nonspecific antilisterial activity induced by viable
M. bovis BCG (33). In the model of secondary
infection, Samsom et al. showed that the resistance was not dependent
on RNI (28). It is suggested that the secondary infection is
different from the primary infection in the killing mechanisms of
L. monocytogenes. In several in vitro assays, when macrophages were activated by IFN-
and LPS or tumor necrosis factor
alpha preinfection, no contribution of RNI to the listericidal mechanisms was observed (12, 16, 23). It appears that the artificial in vitro conditions obtained by using recombinant cytokines or LPS which is not present in L. monocytogenes do not
always represent the actual infection in vivo.
In the present study, we developed an in vitro assay system which may
reproduce the actual L. monocytogenes infection without using recombinant cytokines or LPS but using immune spleen cells to
clarify the mechanisms of killing in the infection. We first examined
the kinetics of intracellular killing and IFN-
production by
macrophages cultured with normal or immune spleen cells after infection. The difference in the bactericidal activity of macrophages cultured with normal or immune spleen cells was not as significant as
expected (Fig. 1). It appeared that a time lag in IFN-
production in
culture (Fig. 2) resulted in the time lag in macrophage activation and
a difference in bacterial killing. It was interesting that RNI but not
ROI played a critical role in antilisterial defense induced by both
normal and immune spleen cells in this assay system (Fig. 4). In both
cultures, macrophages were activated postinfection; therefore, we next
examined the activity and mechanisms of killing used by macrophages
activated by the addition of killed L. monocytogenes antigen
and immune spleen cells pre- and postinfection. It was evident that the
killing activity of macrophages activated preinfection differed from
that of macrophages activated postinfection (Fig. 5) and that ROI
played a critical role in antilisterial mechanisms of macrophages
activated preinfection (Fig. 6). These results are consistent with
those of our previous study, in which macrophages were activated
preinfection (23). It became clear that there are apparent
differences in the killing mechanisms between macrophages activated at
the pre- and postinfection stages.
There may be an argument about whether the in vitro situation employed
in the present study actually takes place in vivo. During the course of
primary infection in mice, infected macrophages may be activated at
some later time by IFN-
secreted by NK cells or in association with
the development of antigen-specific T cells (activation postinfection),
and immunologically activated macrophages may engulf the bacteria upon
secondary infection (activation preinfection). Therefore, we believe
that the present experimental data obtained in vitro are relevant to
the in vivo phenomena.
A virulent strain of L. monocytogenes is able to secrete
listeriolysin O, which has been shown to be a major virulence factor involved in the escape of this bacterium from the phagosomal
compartment to the cytoplasm of macrophages (6, 10, 25). de
Chastellier and Berche determined the percentages of L. monocytogenes in the cell compartments by quantitative assessment
at different times after infection (7). They reported that
about 14% of bacteria were found in the cytoplasm within 1 h
after infection and that the proportion of bacteria reached about 50%
4 h after infection. These data suggest that the bacteria begin to
escape from the phagosome immediately after infection and that a
considerable number of them reach the cytoplasm before the macrophages
are activated by cocultivation with spleen cells in our assay. It is
conceivable that the bacteria in the cytoplasm are free from the attack
by ROI, since superoxide-forming NADPH oxidase is localized in
phagocytic vesicles but not in the cytosol (30), whereas RNI
can contribute to the killing of cytoplasmic bacteria. On the other
hand, the access of L. monocytogenes to the cytoplasm inside
activated macrophages is limited, as Portnoy et al. reported (26). Accordingly, bacteria are not able to escape from the phagosome when macrophages are activated preinfection, and so they are
killed mainly by ROI.
Thus, the present study has revealed that the contributions of ROI and
RNI to listericidal mechanisms of macrophages are different between
macrophages activated at the pre- and postinfection stages. Instead of
activating macrophages by recombinant cytokines or LPS, we have
employed the addition of immune spleen cells plus killed L. monocytogenes cell antigens to mimic the in vivo infection. Therefore, it is likely that ROI contributes mainly to the defense against secondary L. monocytogenes infection whereas RNI
contributes mainly to the defense against primary infection. The
present in vitro assay system may provide a tool for a further analysis
of the killing mechanisms used by macrophages operating in an in vivo
situation.
 |
ACKNOWLEDGMENTS |
This study was supported by grants-in-aid for scientific research
from the Ministry of Education, Science, Culture and Sports, Japan, and
"Research for the Future" Program of the Japan Society for the
Promotion of Science.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Bacteriology, Niigata University School of Medicine, 1-757, Asahimachi-dori, Niigata 951-8510, Japan. Phone: (81)25-227-2110. Fax:
(81)25-227-0762. E-mail: sohya{at}med.niigata-u.ac.jp.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Adams, L. B.,
J. B. Hibbs, Jr.,
R. R. Taintor, and J. L. Krahenbuhl.
1990.
Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine.
J. Immunol.
144:2725-2792[Abstract].
|
| 2.
|
Boockvar, K. S.,
D. L. Granger,
R. M. Poston,
M. Maybodi,
M. K. Washington,
J. B. Hibbs, Jr., and R. L. Kurlander.
1994.
Nitric oxide produced during murine listeriosis is protective.
Infect. Immun.
62:1089-1100[Abstract/Free Full Text].
|
| 3.
|
Brieland, J. K.,
D. G. Remick,
P. T. Freeman,
M. C. Hurley,
J. C. Fantone, and N. C. Engleberg.
1995.
In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide.
Infect. Immun.
63:3253-3258[Abstract].
|
| 4.
|
Chan, J.,
Y. Xing,
R. S. Magliozzo, and B. R. Bloom.
1992.
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.
J. Exp. Med.
175:1111-1122[Abstract/Free Full Text].
|
| 5.
|
Conlan, J. W.
1997.
Critical roles of neutrophils in host defense against experimental systemic infection of mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica.
Infect. Immun.
65:630-635[Abstract].
|
| 6.
|
Cossart, P.,
M. F. Vincente,
J. Mengaud,
F. Baquero,
J. C. Perez-Diaz, and P. Berche.
1989.
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation.
Infect. Immun.
57:3629-3636[Abstract/Free Full Text].
|
| 7.
|
de Chastellier, C., and P. Berche.
1994.
Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria.
Infect. Immun.
62:543-553[Abstract/Free Full Text].
|
| 8.
|
Drapier, J. C.,
J. Wietzerbin, and J. B. Hibbs, Jr.
1988.
Interferon- and tumor necrosis factor induced the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
Eur. J. Immunol.
18:1587-1592[Medline].
|
| 9.
|
Flesch, I. E. A., and S. H. E. Kaufmann.
1991.
Mechanisms involved in mycobacterial growth inhibition by interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates.
Infect. Immun.
59:3213-3218[Abstract/Free Full Text].
|
| 10.
|
Gaillard, J. L.,
P. Berche, and P. Sansonetti.
1986.
Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes.
Infect. Immun.
52:50-55[Abstract/Free Full Text].
|
| 11.
|
Gregory, S. H.,
E. J. Wing,
R. A. Hoffman, and R. L. Simmons.
1993.
Reactive nitrogen intermediates suppress the primary immunologic response to Listeria.
J. Immunol.
150:2901-2909[Abstract].
|
| 12.
|
Inoue, S.,
S.-I. Itagaki, and F. Amano.
1995.
Intracellular killing of Listeria monocytogenes in the J774.1 macrophage-like cell line and the lipopolysaccharide (LPS)-resistant mutant LPS1916 cell line defective in the generation of reactive oxygen intermediates after LPS treatment.
Infect. Immun.
63:1876-1886[Abstract].
|
| 13.
|
Kawamura, I.,
H. Tsukada,
H. Yoshikawa,
M. Fujita,
K. Nomoto, and M. Mitsuyama.
1992.
IFN- -producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice.
J. Immunol.
148:2887-2893[Abstract].
|
| 14.
|
Ladel, C. H.,
I. E. A. Flesch,
J. Arnoldi, and S. H. E. Kaufmann.
1994.
Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection.
J. Immunol.
153:3116-3122[Abstract].
|
| 15.
|
Langermans, J. A. M.,
M. E. B. van der Hulst,
P. H. Nibbering,
P. S. Hiemstra,
L. Fransen, and R. van Furth.
1992.
Interferon- -induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous TNF- .
J. Immunol.
148:568-574[Abstract].
|
| 16.
|
Leenen, P. J.,
B. P. Canono,
D. A. Drevets,
J. S. Voerman, and P. A. Campbell.
1994.
TNF- and IFN- stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner.
J. Immunol.
153:5141-5147[Abstract].
|
| 17.
|
Liew, F. Y.,
Y. Li, and S. Millot.
1990.
Tumor necrosis factor- synergizes with IFN- in mediating killing of Leishmania major through the induction of nitric oxide.
J. Immunol.
144:4794-4797[Abstract].
|
| 18.
|
Mackaness, G. B.
1962.
Cellular resistance to infection.
J. Exp. Med.
116:381-417[Abstract].
|
| 19.
|
MacMicking, J. D.,
C. Nathan,
G. Hom,
N. Chartrain,
D. S. Fletcher,
M. Trumbauer,
K. Stevens,
Q. Xie,
K. Sokol,
N. Hutchinson,
H. Chen, and J. S. Mudgett.
1995.
Altered response to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.
Cell
81:641-650[Medline].
|
| 20.
|
Martin, J. H., and S. W. Edward.
1994.
Interferon- enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production.
Immunology
81:592-597[Medline].
|
| 21.
|
Nathan, C. F.,
H. W. Murray,
M. E. Wiebe, and B. Y. Rubin.
1983.
Identification of interferon- as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
J. Exp. Med.
158:670-689[Abstract/Free Full Text].
|
| 22.
|
Nathan, C. F., and J. B. Hibbs, Jr.
1991.
Role of nitric oxide synthesis in macrophage antimicrobial activity.
Curr. Opin. Immunol.
3:65-70[Medline].
|
| 23.
|
Ohya, S.,
H. Xiong,
Y. Tanabe,
M. Arakawa, and M. Mitsuyama.
1998.
Killing mechanism of Listeria monocytogenes in activated macrophages as determined by an improved assay system.
J. Med. Microbiol.
47:211-215[Abstract].
|
| 24.
|
Portnoy, D. A.,
T. Chakraborty,
W. Goebel, and P. Cossart.
1992.
Molecular determinants of Listeria monocytogenes pathogenesis.
Infect. Immun.
60:1263-1267[Free Full Text].
|
| 25.
|
Portnoy, D. A.,
P. S. Jacks, and D. J. Hinrichs.
1988.
Role of hemolysin for the intracellular growth of Listeria monocytogenes.
J. Exp. Med.
167:1459-1471[Abstract/Free Full Text].
|
| 26.
|
Portnoy, D. A.,
R. D. Schreiber,
P. Connelly, and L. G. Tilney.
1989.
interferon limits access of Listeria monocytogenes to the macrophage cytoplasm.
J. Exp. Med.
170:2141-2146[Abstract/Free Full Text].
|
| 27.
|
Samsom, J. N.,
A. Annema,
P. H. P. Groeneveld,
N. van Rooijen,
J. A. M. Langermans, and R. van Furth.
1997.
Elimination of resident macrophages from the livers and spleens of immune mice impairs acquired resistance against a secondary Listeria monocytogenes infection.
Infect. Immun.
65:986-993[Abstract].
|
| 28.
|
Samsom, J. N.,
J. A. M. Langermans,
P. H. P. Groeneveld, and R. van Furth.
1996.
Acquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediates.
Infect. Immun.
64:1197-1202[Abstract].
|
| 29.
|
Tsukada, H.,
I. Kawamura,
M. Arakawa,
K. Nomoto, and M. Mitsuyama.
1991.
Dissociated development of T cells mediating delayed-type hypersensitivity and protective T cells against Listeria monocytogenes and their functional difference in lymphokine production.
Infect. Immun.
59:3589-3595[Abstract/Free Full Text].
|
| 30.
|
Wakeyama, H.,
K. Takeshige,
R. Takayanagi, and S. Minakami.
1982.
Superoxide-forming NADPH oxidase preparation of pig polymorphonuclear leukocytes.
Biochem. J.
205:593-601[Medline].
|
| 31.
|
Xiong, H.,
I. Kawamura,
T. Nishibori, and M. Mitsuyama.
1996.
Suppression of IFN- production from Listeria monocytogenes-specific T cells by endogenously produced nitric oxide.
Cell. Immunol.
172:118-125[Medline].
|
| 32.
|
Xiong, H.,
T. Nishibori,
S. Ohya,
Y. Tanabe, and M. Mitsuyama.
1996.
Involvement of various combinations of endogenous inflammatory cytokines in Listeria monocytogenes-induced expression of inducible nitric oxide synthase in mice.
FEMS Immunol. Med. Microbiol.
16:257-266[Medline].
|
| 33.
|
Yang, J.,
I. Kawamura, and M. Mitsuyama.
1997.
Involvement of inflammatory cytokines and nitric oxide in the expression of nonspecific resistance to Listeria monocytogenes in mice induced by viable but not killed Mycobacterium bovis BCG.
Microb. Pathog.
22:79-88[Medline].
|
| 34.
|
Yoshikawa, H.,
I. Kawamura,
M. Fujita,
H. Tsukada,
M. Arakawa, and M. Mitsuyama.
1993.
Membrane damage and interleukin-1 production in murine macrophages exposed to listeriolysin O.
Infect. Immun.
61:1334-1339[Abstract/Free Full Text].
|
Infection and Immunity, September 1998, p. 4043-4049, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zwaferink, H., Stockinger, S., Reipert, S., Decker, T.
(2008). Stimulation of Inducible Nitric Oxide Synthase Expression by Beta Interferon Increases Necrotic Death of Macrophages upon Listeria monocytogenes Infection. Infect. Immun.
76: 1649-1656
[Abstract]
[Full Text]
-
Ustyugova, I. V., Frost, L. L., VanDyke, K., Brundage, K. M., Schafer, R., Barnett, J. B.
(2007). 3,4-Dichloropropionaniline Suppresses Normal Macrophage Function. Toxicol Sci
97: 364-374
[Abstract]
[Full Text]
-
Huang, B., Zhao, J., Shen, S., Li, H., He, K.-L., Shen, G.-X., Mayer, L., Unkeless, J., Li, D., Yuan, Y., Zhang, G.-M., Xiong, H., Feng, Z.-H.
(2007). Listeria monocytogenes Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 Signaling. Cancer Res.
67: 4346-4352
[Abstract]
[Full Text]
-
Myers, J. T., Tsang, A. W., Swanson, J. A.
(2003). Localized Reactive Oxygen and Nitrogen Intermediates Inhibit Escape of Listeria monocytogenes from Vacuoles in Activated Macrophages. J. Immunol.
171: 5447-5453
[Abstract]
[Full Text]
-
Antonini, J. M., Roberts, J. R., Jernigan, M. R., Yang, H.-M., Ma, J. Y. C., Clarke, R. W.
(2002). Residual Oil Fly Ash Increases the Susceptibility to Infection and Severely Damages the Lungs after Pulmonary Challenge with a Bacterial Pathogen. Toxicol Sci
70: 110-119
[Abstract]
[Full Text]
-
Musso, T., Badolato, R., Ravarino, D., Stornello, S., Panzanelli, P., Merlino, C., Savoia, D., Cavallo, R., Ponzi, A. N., Zucca, M.
(2001). Interaction of Bartonella henselae with the Murine Macrophage Cell Line J774: Infection and Proinflammatory Response. Infect. Immun.
69: 5974-5980
[Abstract]
[Full Text]
-
Vazquez-Boland, J. A., Kuhn, M., Berche, P., Chakraborty, T., Dominguez-Bernal, G., Goebel, W., Gonzalez-Zorn, B., Wehland, J., Kreft, J.
(2001). Listeria Pathogenesis and Molecular Virulence Determinants. Clin. Microbiol. Rev.
14: 584-640
[Abstract]
[Full Text]
-
Remer, K. A., Jungi, T. W., Fatzer, R., Tauber, M. G., Leib, S. L.
(2001). Nitric Oxide Is Protective in Listeric Meningoencephalitis of Rats. Infect. Immun.
69: 4086-4093
[Abstract]
[Full Text]
-
Ishiguro, T., Naito, M., Yamamoto, T., Hasegawa, G., Gejyo, F., Mitsuyama, M., Suzuki, H., Kodama, T.
(2001). Role of Macrophage Scavenger Receptors in Response to Listeria monocytogenes Infection in Mice. Am. J. Pathol.
158: 179-188
[Abstract]
[Full Text]
-
Sprong, R. C., Hulstein, M. F. E., van der Meer, R.
(2000). Quantifying Translocation of Listeria monocytogenes in Rats by Using Urinary Nitric Oxide-Derived Metabolites. Appl. Environ. Microbiol.
66: 5301-5305
[Abstract]
[Full Text]
-
Vazquez-Torres, A., Jones-Carson, J., Mastroeni, P., Ischiropoulos, H., Fang, F. C.
(2000). Antimicrobial Actions of the NADPH Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. I. Effects on Microbial Killing by Activated Peritoneal Macrophages In Vitro. J. Exp. Med.
192: 227-236
[Abstract]
[Full Text]